SIMULATIONS PLUS INC (SLP) Stock News
NASDAQ:SLP - Nasdaq - US8292141053 - Common Stock - Currency: USD
SLP Latest News, Press Relases and Analysis
Dolby Q2 Earnings Beat Estimates, Revenue Miss, Stock Down
DLB's Q2 earnings rise year over year and beat estimates. Revenues grow but lag expectations.
Blackbaud's Q1 Earnings Beat Estimates & Rise Y/Y, Revenues Down
BLKB's first-quarter earnings and revenues surpass estimates. It reiterates its guidance for full-year 2025.
ANSYS Q1 Earnings & Revenues Miss Estimates, Increase Y/Y, Stock Falls
ANSS first-quarter earnings and revenues lag estimates. The top line rises year over year, driven by strong maintenance, service and subscription lease growth.
SAP's Q1 Earnings & Revenues Up Y/Y on Cloud Demand, Stock Up
SAP's first-quarter 2025 earnings and revenues increase year over year. It remains confident in its growth trajectory and has reiterated its outlook.
3 No-Brainer Energy Stocks to Buy Right Now
Demand drivers such as artificial inteligence (AI) data centers, the onshoring of manufacturing, and the electrification of everything will power a 55% surge in electricity demand by 2040, according to some estimates. Given the continued concerns surrounding climate change, this power will need to come from cleaner sources, including renewables, natural gas, and nuclear. This forecast makes energy companies focused on supporting growing electricity demand look like no-brainer investments right now.
Simulations Plus Supports New FDA Roadmap for Reducing Animal Testing in Preclinical Safety Studies
Badger Meter Q1 Earnings Beat on Solid Revenue Growth, Shares Soar 10%
BMI's Q1 2025 performance is powered by the continued adoption of its digital water solutions and synergy from the SmartCover acquisition.
Simulations Plus Reports Second Quarter Fiscal 2025 Financial Results
Simulations Plus Announces Second Quarter Fiscal Year 2025 Earnings and Conference Call Date
Simulations Plus to Present at the KeyBanc Capital Markets Virtual Healthcare Investor Forum
Simulations Plus to Participate in Upcoming Healthcare Investor Conferences
Simulations Plus and Enabling Technologies Consortium Announce Strategic Collaboration to Advance GastroPlus® Enhancements
Simulations Plus Supported Development of Majority of FDA-Approved Drugs in 2024
Simulations Plus Reports First Quarter Fiscal 2025 Financial Results
Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call Date
Simulations Plus to Participate in the BTIG Digital Health Forum
